BIOMAT Database Logo BIOMAT Database Logo

[Treatment of essential hypertension with prindolol]. 1977

J Kuska, and Z Sledzinski, and F Kokot

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Kuska, and Z Sledzinski, and F Kokot
A comparison of propranolol and prindolol in the treatment of essential hypertension.
April 1974, Current therapeutic research, clinical and experimental,
J Kuska, and Z Sledzinski, and F Kokot
Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.
November 1976, Klinische Wochenschrift,
J Kuska, and Z Sledzinski, and F Kokot
Treatment of coexistent angina pectoris and hypertension with prindolol.
January 1975, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J Kuska, and Z Sledzinski, and F Kokot
Prindolol in hypertension.
June 1971, The Medical journal of Australia,
J Kuska, and Z Sledzinski, and F Kokot
Methyldopa combined with prindolol in the treatment of severe hypertension.
August 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J Kuska, and Z Sledzinski, and F Kokot
[Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
November 1975, MMW, Munchener medizinische Wochenschrift,
J Kuska, and Z Sledzinski, and F Kokot
The use of prindolol (Visken) in the treatment of hypertension.
August 1972, The Medical journal of Australia,
J Kuska, and Z Sledzinski, and F Kokot
Prindolol in the management of hypertension.
May 1974, The New Zealand medical journal,
J Kuska, and Z Sledzinski, and F Kokot
[Effect of Prindolol on intra-arterial pressure and plasma renin activity in essential hypertension].
December 1976, Die Medizinische Welt,
J Kuska, and Z Sledzinski, and F Kokot
Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol).
December 1976, Clinical science and molecular medicine. Supplement,
Copied contents to your clipboard!